Morning Briefing
Summaries of health policy coverage from major news organizations
Keeping HIV Patients On ART Will Have Long-Term Economic Benefits, Study Shows
Investments to keep 3.5 million people living with HIV on antiretroviral drugs provided by programs co-financed through the Global Fund to Fight AIDS, Tuberculosis and Malaria through 2020 will cost an estimated $14.2 billion, but "the financial savings would amount to between $12 billion and $34 billion," according to a study published in the journal PLoS One, Sarah Boseley reports in her "Global Health Blog" in the Guardian (10/5).
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
